

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | eosinophil chemotaxis (GO:0048245) | 9.79435942 |
| 2 | eosinophil migration (GO:0072677) | 8.67846143 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 7.47803774 |
| 4 | thrombin receptor signaling pathway (GO:0070493) | 7.25470098 |
| 5 | protein neddylation (GO:0045116) | 6.53458031 |
| 6 | regulation of platelet aggregation (GO:0090330) | 6.44260056 |
| 7 | positive regulation of monocyte chemotaxis (GO:0090026) | 5.92674271 |
| 8 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.78900856 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.57717155 |
| 10 | monocyte chemotaxis (GO:0002548) | 5.52735121 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.45963775 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.45963775 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 5.45963775 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 5.45963775 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 5.45963775 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.45963775 |
| 17 | response to peptidoglycan (GO:0032494) | 5.43854270 |
| 18 | platelet aggregation (GO:0070527) | 5.30582617 |
| 19 | blood coagulation, intrinsic pathway (GO:0007597) | 5.20137714 |
| 20 | pinocytosis (GO:0006907) | 5.15941186 |
| 21 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.15147988 |
| 22 | granulocyte activation (GO:0036230) | 4.98156773 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97327877 |
| 24 | positive regulation of mast cell activation (GO:0033005) | 4.91444971 |
| 25 | microglial cell activation (GO:0001774) | 4.91247597 |
| 26 | adenosine receptor signaling pathway (GO:0001973) | 4.86835156 |
| 27 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.83578628 |
| 28 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.81681612 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 4.77475096 |
| 30 | negative regulation of platelet activation (GO:0010544) | 4.69281936 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 4.58984556 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.52670247 |
| 33 | cellular extravasation (GO:0045123) | 4.48404782 |
| 34 | macrophage activation (GO:0042116) | 4.46646935 |
| 35 | angiogenesis involved in wound healing (GO:0060055) | 4.42563899 |
| 36 | phagocytosis, engulfment (GO:0006911) | 4.41603272 |
| 37 | positive regulation of lymphocyte migration (GO:2000403) | 4.41533826 |
| 38 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.37000696 |
| 39 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.36218842 |
| 40 | regulation of monocyte chemotaxis (GO:0090025) | 4.35899808 |
| 41 | cellular response to ethanol (GO:0071361) | 4.32775616 |
| 42 | neutrophil activation (GO:0042119) | 4.32073224 |
| 43 | lipoxygenase pathway (GO:0019372) | 4.31905468 |
| 44 | negative regulation of norepinephrine secretion (GO:0010700) | 4.27126214 |
| 45 | regulation of integrin activation (GO:0033623) | 4.24067772 |
| 46 | regulation of mononuclear cell migration (GO:0071675) | 4.17148248 |
| 47 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.10437144 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.06066600 |
| 49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.06021356 |
| 50 | lymphocyte chemotaxis (GO:0048247) | 4.05666441 |
| 51 | negative regulation of heart rate (GO:0010459) | 4.02811134 |
| 52 | respiratory burst (GO:0045730) | 4.02083492 |
| 53 | T-helper 1 type immune response (GO:0042088) | 4.01210981 |
| 54 | megakaryocyte development (GO:0035855) | 4.00391710 |
| 55 | positive regulation of antigen processing and presentation (GO:0002579) | 3.99126497 |
| 56 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.95727135 |
| 57 | regulation of lymphocyte migration (GO:2000401) | 3.90231972 |
| 58 | homotypic cell-cell adhesion (GO:0034109) | 3.87265898 |
| 59 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.85783561 |
| 60 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.84018965 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.74863049 |
| 62 | polyamine biosynthetic process (GO:0006596) | 3.74193985 |
| 63 | granulocyte chemotaxis (GO:0071621) | 3.73829402 |
| 64 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.73232710 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.73232710 |
| 66 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.69432030 |
| 67 | * platelet degranulation (GO:0002576) | 3.65806535 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 3.63151276 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.61832906 |
| 70 | platelet formation (GO:0030220) | 3.59290567 |
| 71 | granulocyte migration (GO:0097530) | 3.57513105 |
| 72 | positive regulation of blood coagulation (GO:0030194) | 3.56794612 |
| 73 | positive regulation of hemostasis (GO:1900048) | 3.56794612 |
| 74 | sexual reproduction (GO:0019953) | 3.55822674 |
| 75 | cytidine deamination (GO:0009972) | 3.52823323 |
| 76 | cytidine metabolic process (GO:0046087) | 3.52823323 |
| 77 | cytidine catabolic process (GO:0006216) | 3.52823323 |
| 78 | regulation of macrophage chemotaxis (GO:0010758) | 3.51425580 |
| 79 | dendritic cell chemotaxis (GO:0002407) | 3.50969660 |
| 80 | * platelet activation (GO:0030168) | 3.50658335 |
| 81 | negative regulation of bone mineralization (GO:0030502) | 3.50302104 |
| 82 | regulation of platelet activation (GO:0010543) | 3.48808487 |
| 83 | detection of external biotic stimulus (GO:0098581) | 3.48743130 |
| 84 | regulation of mast cell activation (GO:0033003) | 3.47927514 |
| 85 | negative regulation of response to food (GO:0032096) | 3.46878587 |
| 86 | negative regulation of appetite (GO:0032099) | 3.46878587 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 3.44066939 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 3.41965847 |
| 89 | T cell migration (GO:0072678) | 3.41545330 |
| 90 | positive regulation of mast cell degranulation (GO:0043306) | 3.39851362 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.39851362 |
| 92 | negative regulation of T cell apoptotic process (GO:0070233) | 3.37900368 |
| 93 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37660320 |
| 94 | positive regulation of leukocyte chemotaxis (GO:0002690) | 3.34751462 |
| 95 | positive regulation of leukocyte migration (GO:0002687) | 3.34682684 |
| 96 | regulation of lipoprotein metabolic process (GO:0050746) | 3.34607215 |
| 97 | purinergic receptor signaling pathway (GO:0035587) | 3.32814708 |
| 98 | macrophage chemotaxis (GO:0048246) | 3.32356178 |
| 99 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.31234775 |
| 100 | negative regulation of granulocyte differentiation (GO:0030853) | 3.29813920 |
| 101 | response to host immune response (GO:0052572) | 3.29446305 |
| 102 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29446305 |
| 103 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.27614890 |
| 104 | positive regulation of receptor recycling (GO:0001921) | 3.26949253 |
| 105 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.25970239 |
| 106 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25949017 |
| 107 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.25781957 |
| 108 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.25755573 |
| 109 | dendritic cell migration (GO:0036336) | 3.22527427 |
| 110 | myeloid leukocyte activation (GO:0002274) | 3.20786354 |
| 111 | cyclooxygenase pathway (GO:0019371) | 3.20559538 |
| 112 | positive regulation of coagulation (GO:0050820) | 3.18478348 |
| 113 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.17962698 |
| 114 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.17942147 |
| 115 | negative regulation of protein localization to cell surface (GO:2000009) | 3.17707695 |
| 116 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.16816907 |
| 117 | regulation of tolerance induction (GO:0002643) | 3.16555297 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 3.15060786 |
| 119 | termination of signal transduction (GO:0023021) | 3.14741441 |
| 120 | negative regulation of biomineral tissue development (GO:0070168) | 3.14662765 |
| 121 | * leukocyte chemotaxis (GO:0030595) | 3.13110211 |
| 122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.11439094 |
| 123 | skeletal muscle tissue regeneration (GO:0043403) | 3.08246116 |
| 124 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.05486605 |
| 125 | myeloid leukocyte migration (GO:0097529) | 3.04453863 |
| 126 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.03626128 |
| 127 | neutrophil chemotaxis (GO:0030593) | 3.03384581 |
| 128 | regulation of interferon-alpha production (GO:0032647) | 3.02967665 |
| 129 | lens fiber cell differentiation (GO:0070306) | 3.01233959 |
| 130 | autophagic vacuole fusion (GO:0000046) | 3.00844092 |
| 131 | leukocyte degranulation (GO:0043299) | 3.00824751 |
| 132 | regulation of leukocyte chemotaxis (GO:0002688) | 3.00395148 |
| 133 | regulation of female receptivity (GO:0045924) | 2.99924924 |
| 134 | positive regulation of B cell differentiation (GO:0045579) | 2.99544519 |
| 135 | regulation of mast cell degranulation (GO:0043304) | 2.99133885 |
| 136 | negative regulation of interleukin-12 production (GO:0032695) | 2.98447177 |
| 137 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.98440842 |
| 138 | extracellular fibril organization (GO:0043206) | 2.98254588 |
| 139 | membrane invagination (GO:0010324) | 2.97604298 |
| 140 | superoxide anion generation (GO:0042554) | 2.97079063 |
| 141 | negative regulation of heart contraction (GO:0045822) | 2.96832634 |
| 142 | regulation of regulatory T cell differentiation (GO:0045589) | 2.96427719 |
| 143 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.96148058 |
| 144 | neutrophil migration (GO:1990266) | 2.94943077 |
| 145 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94891501 |
| 146 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.94474791 |
| 147 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.93866365 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.93122438 |
| 149 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91779818 |
| 150 | response to host (GO:0075136) | 2.91779818 |
| 151 | response to host defenses (GO:0052200) | 2.91779818 |
| 152 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.91068838 |
| 153 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91068436 |
| 154 | detection of biotic stimulus (GO:0009595) | 2.89278065 |
| 155 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.88926973 |
| 156 | mast cell activation (GO:0045576) | 2.87875439 |
| 157 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.86606362 |
| 158 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86295537 |
| 159 | regulation of endothelial cell differentiation (GO:0045601) | 2.85736809 |
| 160 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85233905 |
| 161 | negative regulation of cell killing (GO:0031342) | 2.83692532 |
| 162 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.83692532 |
| 163 | regulation of norepinephrine secretion (GO:0014061) | 2.83385023 |
| 164 | regulation of hemostasis (GO:1900046) | 2.83321693 |
| 165 | regulation of blood coagulation (GO:0030193) | 2.83321693 |
| 166 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.83204138 |
| 167 | regulation of apoptotic cell clearance (GO:2000425) | 2.83147345 |
| 168 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.82505860 |
| 169 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81435672 |
| 170 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81251185 |
| 171 | regulation of cholesterol storage (GO:0010885) | 2.80073556 |
| 172 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.79323941 |
| 173 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.79121206 |
| 174 | positive regulation of B cell mediated immunity (GO:0002714) | 2.78440013 |
| 175 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.78440013 |
| 176 | beta-amyloid metabolic process (GO:0050435) | 2.77657923 |
| 177 | vesicle targeting (GO:0006903) | 2.76673307 |
| 178 | negative regulation of stress fiber assembly (GO:0051497) | 2.73818243 |
| 179 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.72947301 |
| 180 | monoamine transport (GO:0015844) | 2.72440617 |
| 181 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71076878 |
| 182 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.70970455 |
| 183 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.70877695 |
| 184 | regulation of thymocyte apoptotic process (GO:0070243) | 2.69921086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.37056842 |
| 2 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.80028212 |
| 3 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.52579083 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90371911 |
| 5 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.85474964 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.43706608 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41638643 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.35418570 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.96636841 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.92023282 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.78774890 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57657312 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49194022 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.44097142 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38544545 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.26844587 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21271828 |
| 18 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17847586 |
| 19 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.14800165 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11484049 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.09998583 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.09163543 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.03031854 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 11.3081405 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98859219 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.95574705 |
| 27 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.89535793 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86289896 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.85443075 |
| 30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78596625 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76287361 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75772043 |
| 33 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.73392834 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71793384 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69076548 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68824594 |
| 37 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.68137767 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66985598 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64801191 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63958702 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60942104 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59618046 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58505849 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58007862 |
| 45 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56312226 |
| 46 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.55662736 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54478890 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54230407 |
| 49 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.53410397 |
| 50 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.52472627 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46934266 |
| 52 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45316133 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43166361 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38691010 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37522169 |
| 56 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35401991 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29729217 |
| 58 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.24485938 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20950414 |
| 60 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20203009 |
| 61 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19751949 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18222560 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17338990 |
| 64 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16093917 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.13634397 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13463168 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09844234 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08452643 |
| 69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08338795 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08034064 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06852704 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03811869 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03678642 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.02905796 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01846472 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01668055 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 1.00766593 |
| 78 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.97443305 |
| 79 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.96130193 |
| 80 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94631453 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94463221 |
| 82 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94035055 |
| 83 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92366244 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91928676 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 0.88720403 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86527334 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86403468 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86353507 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86268177 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85884059 |
| 91 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84799062 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84620509 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84372325 |
| 94 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82690731 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82565011 |
| 96 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.80933436 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80839215 |
| 98 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.79868359 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77845953 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77393709 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77347879 |
| 102 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.76219465 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.74237847 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74223434 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74223434 |
| 106 | * LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.73801835 |
| 107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.73470816 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71785227 |
| 109 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.71489308 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70989188 |
| 111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.70922846 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70801283 |
| 113 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70698065 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69252714 |
| 115 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68989841 |
| 116 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.68884318 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65995793 |
| 118 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65840713 |
| 119 | UTX_26944678_Chip-Seq_JUKART_Human | 0.64411358 |
| 120 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.60557463 |
| 121 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.59453918 |
| 122 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.58830320 |
| 123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.57855061 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.57491725 |
| 125 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.56645687 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.53376106 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53026941 |
| 128 | CJUN_26792858_Chip-Seq_BT549_Human | 0.52184556 |
| 129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.51967756 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48620359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.68121723 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.45647324 |
| 3 | MP0003436_decreased_susceptibility_to | 4.07052958 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.90435561 |
| 5 | MP0009840_abnormal_foam_cell | 3.70128460 |
| 6 | MP0002419_abnormal_innate_immunity | 3.38098926 |
| 7 | MP0005464_abnormal_platelet_physiology | 3.17818176 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.11465658 |
| 9 | MP0000343_altered_response_to | 2.91385946 |
| 10 | MP0006082_CNS_inflammation | 2.81503911 |
| 11 | MP0005083_abnormal_biliary_tract | 2.78798058 |
| 12 | MP0005025_abnormal_response_to | 2.74817381 |
| 13 | MP0009785_altered_susceptibility_to | 2.59373270 |
| 14 | MP0003724_increased_susceptibility_to | 2.50349087 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.47298473 |
| 16 | MP0001790_abnormal_immune_system | 2.42934423 |
| 17 | MP0005387_immune_system_phenotype | 2.42934423 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.41290247 |
| 19 | MP0002723_abnormal_immune_serum | 2.30100204 |
| 20 | MP0001800_abnormal_humoral_immune | 2.27058442 |
| 21 | MP0003303_peritoneal_inflammation | 2.18787566 |
| 22 | MP0005671_abnormal_response_to | 2.18545173 |
| 23 | MP0002736_abnormal_nociception_after | 2.16193636 |
| 24 | MP0002405_respiratory_system_inflammati | 2.14546487 |
| 25 | MP0000685_abnormal_immune_system | 2.05697072 |
| 26 | MP0005084_abnormal_gallbladder_morpholo | 2.01762794 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.01689172 |
| 28 | MP0003690_abnormal_glial_cell | 2.00677969 |
| 29 | MP0001819_abnormal_immune_cell | 1.99059009 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.97845736 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.97696503 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.94670844 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.83517686 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.81364722 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.81297321 |
| 36 | MP0000230_abnormal_systemic_arterial | 1.77595487 |
| 37 | MP0002132_abnormal_respiratory_system | 1.74194083 |
| 38 | MP0003075_altered_response_to | 1.73776852 |
| 39 | MP0004130_abnormal_muscle_cell | 1.71942381 |
| 40 | MP0006054_spinal_hemorrhage | 1.68381512 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.65351300 |
| 42 | MP0000604_amyloidosis | 1.63527432 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.61927617 |
| 44 | MP0001853_heart_inflammation | 1.61549863 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.57408299 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.54139955 |
| 47 | MP0009764_decreased_sensitivity_to | 1.53478611 |
| 48 | MP0003638_abnormal_response/metabolism_ | 1.53300236 |
| 49 | MP0004510_myositis | 1.51245478 |
| 50 | MP0008469_abnormal_protein_level | 1.50797543 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.48495044 |
| 52 | MP0001663_abnormal_digestive_system | 1.44733068 |
| 53 | MP0002254_reproductive_system_inflammat | 1.43815009 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.43031536 |
| 55 | MP0005164_abnormal_response_to | 1.42679147 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.39849122 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.39296368 |
| 58 | MP0000716_abnormal_immune_system | 1.35295027 |
| 59 | MP0005310_abnormal_salivary_gland | 1.35158208 |
| 60 | MP0001727_abnormal_embryo_implantation | 1.35069671 |
| 61 | MP0003828_pulmonary_edema | 1.34389028 |
| 62 | MP0008872_abnormal_physiological_respon | 1.33770522 |
| 63 | MP0003866_abnormal_defecation | 1.32891591 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.31305550 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.30017808 |
| 66 | MP0003879_abnormal_hair_cell | 1.29022230 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.25364034 |
| 68 | MP0005410_abnormal_fertilization | 1.25136097 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.21811737 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 1.20894031 |
| 71 | MP0003448_altered_tumor_morphology | 1.20163195 |
| 72 | MP0003279_aneurysm | 1.19829284 |
| 73 | MP0004036_abnormal_muscle_relaxation | 1.19356625 |
| 74 | MP0000249_abnormal_blood_vessel | 1.17023728 |
| 75 | MP0008775_abnormal_heart_ventricle | 1.16509613 |
| 76 | MP0003300_gastrointestinal_ulcer | 1.16109099 |
| 77 | * MP0002398_abnormal_bone_marrow | 1.14901207 |
| 78 | * MP0002429_abnormal_blood_cell | 1.14254460 |
| 79 | MP0004883_abnormal_blood_vessel | 1.13271549 |
| 80 | MP0005166_decreased_susceptibility_to | 1.10192175 |
| 81 | MP0002722_abnormal_immune_system | 1.09694788 |
| 82 | MP0009763_increased_sensitivity_to | 1.09679937 |
| 83 | MP0000920_abnormal_myelination | 1.07424272 |
| 84 | MP0005390_skeleton_phenotype | 1.05631611 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.01867849 |
| 86 | MP0002653_abnormal_ependyma_morphology | 1.01114686 |
| 87 | MP0002733_abnormal_thermal_nociception | 0.98259413 |
| 88 | MP0008874_decreased_physiological_sensi | 0.97225526 |
| 89 | MP0001851_eye_inflammation | 0.97179447 |
| 90 | MP0004947_skin_inflammation | 0.96118621 |
| 91 | MP0005646_abnormal_pituitary_gland | 0.95247899 |
| 92 | MP0002006_tumorigenesis | 0.93287017 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.92272321 |
| 94 | MP0003186_abnormal_redox_activity | 0.91398750 |
| 95 | MP0009278_abnormal_bone_marrow | 0.90831979 |
| 96 | MP0005409_darkened_coat_color | 0.89713309 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.89384662 |
| 98 | MP0008438_abnormal_cutaneous_collagen | 0.89202871 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.88416017 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.88240408 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.86608571 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.86608571 |
| 103 | * MP0009642_abnormal_blood_homeostasis | 0.86136127 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.86071837 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.85240967 |
| 106 | MP0000858_altered_metastatic_potential | 0.82025374 |
| 107 | MP0009697_abnormal_copulation | 0.80110162 |
| 108 | MP0003795_abnormal_bone_structure | 0.79974440 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.79458183 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.78589798 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.78342205 |
| 112 | MP0001664_abnormal_digestion | 0.77071251 |
| 113 | MP0005165_increased_susceptibility_to | 0.76275038 |
| 114 | MP0000490_abnormal_crypts_of | 0.75267884 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.74236432 |
| 116 | MP0008260_abnormal_autophagy | 0.74065658 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.72403804 |
| 118 | MP0001970_abnormal_pain_threshold | 0.72401232 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.70750545 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.69273857 |
| 121 | MP0004381_abnormal_hair_follicle | 0.68019397 |
| 122 | MP0008873_increased_physiological_sensi | 0.67629740 |
| 123 | MP0004484_altered_response_of | 0.66875236 |
| 124 | MP0005535_abnormal_body_temperature | 0.66518341 |
| 125 | MP0001915_intracranial_hemorrhage | 0.66422076 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.65643107 |
| 127 | MP0005408_hypopigmentation | 0.64546772 |
| 128 | MP0002090_abnormal_vision | 0.63308922 |
| 129 | MP0005023_abnormal_wound_healing | 0.62871765 |
| 130 | MP0006276_abnormal_autonomic_nervous | 0.62810552 |
| 131 | MP0003763_abnormal_thymus_physiology | 0.62370151 |
| 132 | MP0003011_delayed_dark_adaptation | 0.62186776 |
| 133 | MP0005365_abnormal_bile_salt | 0.61420738 |
| 134 | MP0002118_abnormal_lipid_homeostasis | 0.61331002 |
| 135 | MP0000609_abnormal_liver_physiology | 0.60938386 |
| 136 | MP0000371_diluted_coat_color | 0.60343898 |
| 137 | MP0004147_increased_porphyrin_level | 0.60204883 |
| 138 | MP0005085_abnormal_gallbladder_physiolo | 0.59319874 |
| 139 | MP0002933_joint_inflammation | 0.59157900 |
| 140 | MP0008004_abnormal_stomach_pH | 0.58752847 |
| 141 | MP0004019_abnormal_vitamin_homeostasis | 0.58590303 |
| 142 | MP0010329_abnormal_lipoprotein_level | 0.58542496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 8.30862198 |
| 2 | Recurrent abscess formation (HP:0002722) | 7.40986468 |
| 3 | Glomerulonephritis (HP:0000099) | 6.53772820 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.49410978 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.53708989 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.34252804 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.25915966 |
| 8 | Axonal loss (HP:0003447) | 5.14251962 |
| 9 | Agnosia (HP:0010524) | 5.01358316 |
| 10 | Abnormality of complement system (HP:0005339) | 4.94327412 |
| 11 | Disinhibition (HP:0000734) | 4.88071484 |
| 12 | Complement deficiency (HP:0004431) | 4.86487901 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.67389309 |
| 14 | Prostate neoplasm (HP:0100787) | 4.62912098 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.61862848 |
| 16 | Spontaneous hematomas (HP:0007420) | 4.60365776 |
| 17 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.37489185 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 4.32973091 |
| 19 | Petechiae (HP:0000967) | 4.27486266 |
| 20 | Joint hemorrhage (HP:0005261) | 4.09016560 |
| 21 | Poikilocytosis (HP:0004447) | 3.96679426 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.93086039 |
| 23 | Acanthocytosis (HP:0001927) | 3.76125143 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.73745645 |
| 25 | Purpura (HP:0000979) | 3.70265220 |
| 26 | Nephritis (HP:0000123) | 3.69311701 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.69185475 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.58087082 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.54907692 |
| 30 | Recurrent skin infections (HP:0001581) | 3.51849263 |
| 31 | Dyschromatopsia (HP:0007641) | 3.45047848 |
| 32 | Bruising susceptibility (HP:0000978) | 3.43145640 |
| 33 | Upper motor neuron abnormality (HP:0002127) | 3.34127619 |
| 34 | Increased density of long bones (HP:0006392) | 3.31472390 |
| 35 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.30140112 |
| 36 | Obstructive lung disease (HP:0006536) | 3.29453111 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29453111 |
| 38 | Menorrhagia (HP:0000132) | 3.27461087 |
| 39 | Basal ganglia calcification (HP:0002135) | 3.22960093 |
| 40 | Abnormality of the prostate (HP:0008775) | 3.18546127 |
| 41 | Gingivitis (HP:0000230) | 3.15284792 |
| 42 | Epistaxis (HP:0000421) | 3.10916717 |
| 43 | Pathologic fracture (HP:0002756) | 3.04478640 |
| 44 | Large eyes (HP:0001090) | 3.02941739 |
| 45 | Abnormal pupillary function (HP:0007686) | 3.02849111 |
| 46 | Abnormality of lateral ventricle (HP:0030047) | 2.92701199 |
| 47 | Paralysis (HP:0003470) | 2.88237059 |
| 48 | Thick nail (HP:0001805) | 2.81658951 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.81046749 |
| 50 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.77798827 |
| 51 | Cellulitis (HP:0100658) | 2.76922727 |
| 52 | Abnormal platelet volume (HP:0011876) | 2.76365205 |
| 53 | Stomatitis (HP:0010280) | 2.67710477 |
| 54 | Gingival bleeding (HP:0000225) | 2.67256512 |
| 55 | Inappropriate behavior (HP:0000719) | 2.59875086 |
| 56 | Recurrent viral infections (HP:0004429) | 2.57911281 |
| 57 | Increased IgM level (HP:0003496) | 2.53753357 |
| 58 | Pustule (HP:0200039) | 2.52003058 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.48665198 |
| 60 | Periodontitis (HP:0000704) | 2.46130899 |
| 61 | Joint swelling (HP:0001386) | 2.45386463 |
| 62 | Urticaria (HP:0001025) | 2.44613988 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.43351491 |
| 64 | Conjunctival telangiectasia (HP:0000524) | 2.41988664 |
| 65 | Encephalitis (HP:0002383) | 2.41037807 |
| 66 | Colitis (HP:0002583) | 2.38165781 |
| 67 | Decreased central vision (HP:0007663) | 2.37011232 |
| 68 | Abnormal number of erythroid precursors (HP:0012131) | 2.36757076 |
| 69 | Progressive visual loss (HP:0000529) | 2.36633329 |
| 70 | Arterial thrombosis (HP:0004420) | 2.34423015 |
| 71 | Tinnitus (HP:0000360) | 2.33192935 |
| 72 | Increased mean platelet volume (HP:0011877) | 2.31640373 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.28778475 |
| 74 | Hematochezia (HP:0002573) | 2.24707851 |
| 75 | Hypokinesia (HP:0002375) | 2.23961294 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.23815600 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.23810668 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23810668 |
| 79 | Bone cyst (HP:0012062) | 2.23796601 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22439408 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22439408 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22439408 |
| 83 | Myocardial infarction (HP:0001658) | 2.21719219 |
| 84 | Personality changes (HP:0000751) | 2.21309003 |
| 85 | Meningitis (HP:0001287) | 2.21296118 |
| 86 | Episodic fever (HP:0001954) | 2.18187550 |
| 87 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.18117999 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.16162730 |
| 89 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16162730 |
| 90 | Bone pain (HP:0002653) | 2.16125971 |
| 91 | Abnormal auditory evoked potentials (HP:0006958) | 2.15986304 |
| 92 | Xanthomatosis (HP:0000991) | 2.15694953 |
| 93 | Osteomyelitis (HP:0002754) | 2.14473659 |
| 94 | Dysautonomia (HP:0002459) | 2.10864421 |
| 95 | Myositis (HP:0100614) | 2.10599220 |
| 96 | Chest pain (HP:0100749) | 2.09011510 |
| 97 | Peripheral demyelination (HP:0011096) | 2.08238558 |
| 98 | Aplasia cutis congenita (HP:0001057) | 2.07407804 |
| 99 | Apathy (HP:0000741) | 2.06431518 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.06019531 |
| 101 | Polycythemia (HP:0001901) | 2.05433551 |
| 102 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03632515 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.01532555 |
| 104 | Ventricular fibrillation (HP:0001663) | 1.97356116 |
| 105 | Orchitis (HP:0100796) | 1.97290261 |
| 106 | Diminished motivation (HP:0000745) | 1.96684672 |
| 107 | Upper limb muscle weakness (HP:0003484) | 1.96405498 |
| 108 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93997253 |
| 109 | Autoimmune hemolytic anemia (HP:0001890) | 1.93533316 |
| 110 | Retrobulbar optic neuritis (HP:0100654) | 1.91788132 |
| 111 | Optic neuritis (HP:0100653) | 1.91788132 |
| 112 | Vertigo (HP:0002321) | 1.89662374 |
| 113 | Sepsis (HP:0100806) | 1.89299328 |
| 114 | Generalized aminoaciduria (HP:0002909) | 1.88765974 |
| 115 | Agammaglobulinemia (HP:0004432) | 1.88525227 |
| 116 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87100992 |
| 117 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87100992 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87100992 |
| 119 | Chronic otitis media (HP:0000389) | 1.86372560 |
| 120 | Nausea (HP:0002018) | 1.82605582 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 1.82113255 |
| 122 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.82038254 |
| 123 | Recurrent pneumonia (HP:0006532) | 1.81493627 |
| 124 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.77400744 |
| 125 | Absent/shortened dynein arms (HP:0200106) | 1.77400744 |
| 126 | Spontaneous abortion (HP:0005268) | 1.76878354 |
| 127 | Leukocytosis (HP:0001974) | 1.76005416 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.75924735 |
| 129 | Papillary thyroid carcinoma (HP:0002895) | 1.74522778 |
| 130 | Increased serum ferritin (HP:0003281) | 1.72361570 |
| 131 | Abnormal platelet function (HP:0011869) | 1.71956928 |
| 132 | Impaired platelet aggregation (HP:0003540) | 1.71956928 |
| 133 | Abnormality of male internal genitalia (HP:0000022) | 1.71030206 |
| 134 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70659295 |
| 135 | Autoimmune thrombocytopenia (HP:0001973) | 1.70267869 |
| 136 | Abnormal ciliary motility (HP:0012262) | 1.70036962 |
| 137 | Hyperthyroidism (HP:0000836) | 1.68442253 |
| 138 | Thrombophlebitis (HP:0004418) | 1.62463051 |
| 139 | Abnormality of binocular vision (HP:0011514) | 1.62014565 |
| 140 | Diplopia (HP:0000651) | 1.62014565 |
| 141 | Male infertility (HP:0003251) | 1.61546937 |
| 142 | Thyroid-stimulating hormone excess (HP:0002925) | 1.58371339 |
| 143 | Hypochromic microcytic anemia (HP:0004840) | 1.56066075 |
| 144 | Granulocytopenia (HP:0001913) | 1.55468232 |
| 145 | Keratoconjunctivitis sicca (HP:0001097) | 1.54942148 |
| 146 | Muscle fibrillation (HP:0010546) | 1.53359502 |
| 147 | Eosinophilia (HP:0001880) | 1.52023081 |
| 148 | Pulmonary embolism (HP:0002204) | 1.51647319 |
| 149 | Vasculitis (HP:0002633) | 1.48161033 |
| 150 | Leiomyosarcoma (HP:0100243) | 1.46487363 |
| 151 | Uterine leiomyosarcoma (HP:0002891) | 1.46487363 |
| 152 | Amaurosis fugax (HP:0100576) | 1.46411409 |
| 153 | Hypophosphatemic rickets (HP:0004912) | 1.46310688 |
| 154 | Microcytic anemia (HP:0001935) | 1.46292184 |
| 155 | Mucosal telangiectasiae (HP:0100579) | 1.44062822 |
| 156 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.43536293 |
| 157 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.43398743 |
| 158 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.43398743 |
| 159 | Distal lower limb amyotrophy (HP:0008944) | 1.43304995 |
| 160 | Biliary tract neoplasm (HP:0100574) | 1.42019601 |
| 161 | Arthralgia (HP:0002829) | 1.41242667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 8.37610581 |
| 2 | MST4 | 4.94203935 |
| 3 | RIPK4 | 3.54265766 |
| 4 | EIF2AK1 | 2.82249130 |
| 5 | TGFBR2 | 2.65536638 |
| 6 | TYK2 | 2.64235564 |
| 7 | MAP3K14 | 2.62043480 |
| 8 | IRAK3 | 2.29147256 |
| 9 | GRK7 | 2.13991504 |
| 10 | IRAK4 | 2.10301888 |
| 11 | TEC | 2.05812118 |
| 12 | BMPR1B | 2.00748050 |
| 13 | BTK | 1.97971440 |
| 14 | TXK | 1.91628914 |
| 15 | LYN | 1.63390840 |
| 16 | ILK | 1.60156921 |
| 17 | MAP4K1 | 1.54703654 |
| 18 | MAP3K10 | 1.51461959 |
| 19 | SYK | 1.45501784 |
| 20 | DMPK | 1.45110376 |
| 21 | YES1 | 1.44950884 |
| 22 | PIM2 | 1.37177143 |
| 23 | PBK | 1.35771930 |
| 24 | IKBKB | 1.34608642 |
| 25 | STK3 | 1.33003039 |
| 26 | TGFBR1 | 1.32283099 |
| 27 | CLK1 | 1.30226546 |
| 28 | STK10 | 1.21138323 |
| 29 | MAP3K12 | 1.20020097 |
| 30 | TBK1 | 1.19342864 |
| 31 | NME2 | 1.18703649 |
| 32 | HCK | 1.17796560 |
| 33 | CSF1R | 1.17629826 |
| 34 | EPHB2 | 1.17117496 |
| 35 | LCK | 1.15018899 |
| 36 | KIT | 1.13412697 |
| 37 | SCYL2 | 1.11579376 |
| 38 | PAK1 | 1.10757269 |
| 39 | TAOK3 | 1.08075366 |
| 40 | MAPKAPK3 | 1.06360198 |
| 41 | PIK3CG | 1.06018092 |
| 42 | ITK | 1.04159706 |
| 43 | ZAP70 | 1.03047787 |
| 44 | LMTK2 | 1.01637830 |
| 45 | PLK2 | 1.01257591 |
| 46 | BMPR2 | 0.97945124 |
| 47 | CSK | 0.97436365 |
| 48 | PAK4 | 0.97059154 |
| 49 | EPHB1 | 0.94933335 |
| 50 | IKBKE | 0.93965205 |
| 51 | PIM1 | 0.93772394 |
| 52 | SIK3 | 0.93492439 |
| 53 | TAOK1 | 0.91002962 |
| 54 | TNK2 | 0.89695047 |
| 55 | MARK3 | 0.89050407 |
| 56 | TAOK2 | 0.88765959 |
| 57 | ACVR1B | 0.87097466 |
| 58 | STK24 | 0.86771024 |
| 59 | MAPK12 | 0.85338360 |
| 60 | IRAK1 | 0.85282131 |
| 61 | EIF2AK2 | 0.84282373 |
| 62 | JAK1 | 0.83814538 |
| 63 | ARAF | 0.83294213 |
| 64 | MATK | 0.77970366 |
| 65 | FES | 0.77776136 |
| 66 | PRKCD | 0.76886046 |
| 67 | PDK1 | 0.76820765 |
| 68 | MAP3K5 | 0.75486732 |
| 69 | JAK2 | 0.75361306 |
| 70 | MST1R | 0.74784268 |
| 71 | IGF1R | 0.74274060 |
| 72 | FGR | 0.71847895 |
| 73 | ERBB2 | 0.71722261 |
| 74 | MAP2K3 | 0.69138386 |
| 75 | EPHA3 | 0.68501540 |
| 76 | ADRBK2 | 0.67945059 |
| 77 | PKN1 | 0.67710554 |
| 78 | TRPM7 | 0.66428351 |
| 79 | ABL2 | 0.66328327 |
| 80 | EGFR | 0.64401531 |
| 81 | RET | 0.64085492 |
| 82 | TESK2 | 0.63324728 |
| 83 | STK4 | 0.61848375 |
| 84 | KDR | 0.61803530 |
| 85 | TNIK | 0.60914276 |
| 86 | MKNK2 | 0.60558022 |
| 87 | PDPK1 | 0.60179987 |
| 88 | DAPK2 | 0.60064466 |
| 89 | MAP3K11 | 0.57766423 |
| 90 | MAPKAPK5 | 0.56982435 |
| 91 | CHUK | 0.55761854 |
| 92 | CDK6 | 0.54955980 |
| 93 | MOS | 0.53467598 |
| 94 | BMX | 0.53420167 |
| 95 | FER | 0.51664492 |
| 96 | MELK | 0.51224483 |
| 97 | MAP2K1 | 0.50812312 |
| 98 | NUAK1 | 0.50642451 |
| 99 | PRKACG | 0.50595850 |
| 100 | FYN | 0.47650603 |
| 101 | PRKCQ | 0.47102189 |
| 102 | PDGFRB | 0.46071659 |
| 103 | CAMKK2 | 0.44519268 |
| 104 | ADRBK1 | 0.44466248 |
| 105 | MKNK1 | 0.43835231 |
| 106 | GRK5 | 0.42846613 |
| 107 | JAK3 | 0.39659214 |
| 108 | ABL1 | 0.38754678 |
| 109 | NEK9 | 0.37382764 |
| 110 | DAPK3 | 0.36763198 |
| 111 | CDK8 | 0.35923654 |
| 112 | MAPKAPK2 | 0.35167207 |
| 113 | HIPK2 | 0.35081540 |
| 114 | LRRK2 | 0.34393272 |
| 115 | NLK | 0.34107474 |
| 116 | TRIM28 | 0.33264968 |
| 117 | MYLK | 0.32162243 |
| 118 | MAP3K3 | 0.32125729 |
| 119 | CAMKK1 | 0.31512348 |
| 120 | MAP2K2 | 0.31473601 |
| 121 | PAK3 | 0.31329875 |
| 122 | PRKD1 | 0.31289151 |
| 123 | PNCK | 0.31179021 |
| 124 | IRAK2 | 0.30964181 |
| 125 | CAMK1D | 0.30885544 |
| 126 | MAP3K1 | 0.30618039 |
| 127 | GRK1 | 0.30354450 |
| 128 | INSRR | 0.29525444 |
| 129 | RAF1 | 0.29000594 |
| 130 | PRKCB | 0.28458829 |
| 131 | TLK1 | 0.28153749 |
| 132 | DAPK1 | 0.26639229 |
| 133 | MAPK4 | 0.25958593 |
| 134 | GRK6 | 0.25563111 |
| 135 | RPS6KA4 | 0.25297722 |
| 136 | PRKG1 | 0.25044674 |
| 137 | SRC | 0.24909329 |
| 138 | DYRK1B | 0.24135956 |
| 139 | PTK2B | 0.23519218 |
| 140 | PRKCA | 0.23319794 |
| 141 | MAPK13 | 0.22896638 |
| 142 | RPS6KA6 | 0.22742831 |
| 143 | TTN | 0.22310212 |
| 144 | MINK1 | 0.21500276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.44740357 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.97073195 |
| 3 | Pertussis_Homo sapiens_hsa05133 | 2.92306174 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81397893 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.64632893 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.60902302 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.48009411 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42385355 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40994433 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.29804399 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.24726213 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24211174 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.19675890 |
| 14 | Salmonella infection_Homo sapiens_hsa05132 | 2.17435690 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 2.12652622 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.08024281 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.05226578 |
| 18 | Malaria_Homo sapiens_hsa05144 | 2.02170723 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99798500 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.79096893 |
| 21 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.77882771 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72648177 |
| 23 | Prion diseases_Homo sapiens_hsa05020 | 1.71307364 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69107858 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65171213 |
| 26 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64626800 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.64406163 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.56486264 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56149565 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.54051707 |
| 31 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.50602040 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.47393635 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46282599 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43100975 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42115070 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30379510 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27879599 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26066150 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.24449236 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20637988 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18583311 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18134545 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10731171 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 1.07217867 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06257682 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.05307298 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04220159 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04105797 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03290201 |
| 50 | Ribosome_Homo sapiens_hsa03010 | 1.02209126 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02176666 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97508945 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.95525231 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95368717 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.93378057 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93265105 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92414442 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90825941 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 0.90619250 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90045674 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89719728 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86796134 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85993321 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84577795 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84426565 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 0.82692884 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80838086 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80721611 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79385177 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78038408 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.77686418 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75235496 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75214719 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75138866 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74382753 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71048424 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70475245 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69353023 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67888700 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.66768431 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66595215 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63172765 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62170895 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61575535 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60679142 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59932728 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.59023029 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57292564 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54679654 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54234016 |
| 91 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53857684 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53463579 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52076263 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50207360 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.50045658 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49788686 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49295569 |
| 98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48476410 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47179460 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45803782 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.45614812 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45601227 |
| 103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45221336 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44719829 |
| 105 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43823362 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42595458 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41892035 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41220930 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41195709 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40963702 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40916741 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39179924 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35007432 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34440757 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.32735324 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31648684 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.30782101 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28542541 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.26406813 |
| 120 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24777745 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24292785 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.23291086 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21462362 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20178002 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.19977540 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.19828969 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19514423 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19348689 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18883204 |
| 130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16647226 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15906219 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12112177 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.11749673 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.11706796 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.08382740 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.07964098 |
| 137 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.07656211 |
| 138 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.07543984 |
| 139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06934447 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.06308056 |
| 141 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.05435848 |

